EFPIA - NEWSLETTER

EFPIA Newsletter 20 October 2022

News

20 October 2022 Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital...

Blogs

19 October 2022 Striving towards better breast cancer outcomes: Improving survivorship through screening, treatment...

We stand with the women and men who have faced a life-changing diagnosis and remember those we have lost due to this...

Events

02 NOV 2022

Innovation in pharmaceuticals is changing the world. How to ensure their availability... Riga, Latvia

Learn more →

15 NOV 2022

EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION Brussels

An EU Health Coalition event

Learn more →

23 NOV 2022

11th Strategic Conference Value of Innovation: Outcomes of treatment at the heart... Hybrid - Ljubljana

Organised by the Forum of International Research and Development Pharmaceutical Companies.

Learn more →

12 DEC 2022

Enhancing patient-centric outcome measures and clinical trials with Digital Health... Virtual event

Last chance to register!

Learn more →

The Power of Innovation

Through the Power of Innovation series, we are exploring the real impact of innovation; on patients, on healthcare systems and society as a whole.

What we are reading

Alzheimer’s disease: Building hope for a better future 18 October 2022 (Euractiv)

Breakthroughs in Latvia, with More Innovative Drugs than Ever Before 18 October 2022 (PharmaBoardroom)

Europe Tackles Digital Endpoints in Drug Development 12 October 2022 (Applied Clinical Trials)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶